CIK 0001731348 · Large accelerated filer
Tilray Brands, Inc.
Sign in to watch- Ticker
- TLRY
- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- FY end
- May 31
- Entity type
- operating
- EIN
- 824310622
- Phone
- 519.322.8800
- Business address
- 445 PARK AVENUE, NEW YORK, NY, 10022
- Former names
- Tilray, Inc.
- 4 Option exercise Director acquired 3,858 shares (option exercise)
- 4 Option exercise Director acquired 3,858 shares (option exercise)
- 4 Option exercise Director acquired 3,858 shares (option exercise)
- 4 Option exercise President and CEO acquired 1,909,343 shares (option exercise)
- 4 Option exercise Chief Financial Officer acquired 283,454 shares (option exercise)
- 4 Option exercise Global General Counsel acquired 352,491 shares (option exercise)
- 4 Option exercise Chief Strategy Officer acquired 389,164 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Strategy Officer bought 10,000 shares at $2.05 ($20,500)
- 4 Open-market buy Global General Counsel bought 7,200 shares at $1.98 ($14,256)
- 4 Open-market buy Global General Counsel bought 5,400 shares at $1.87 ($10,098)
- 4 Open-market buy President and CEO bought 53,700 shares at $1.88 ($100,956)
- 4 Open-market buy Chief Financial Officer bought 20,000 shares at $1.87 ($37,400)
- 4 Option exercise Chief Financial Officer acquired 187,852 shares (option exercise)
- 4 Option exercise President and CEO acquired 1,412,428 shares (option exercise)
- 4 Option exercise Global General Counsel acquired 187,852 shares (option exercise)
- 4 Option exercise Chief Strategy Officer acquired 187,852 shares (option exercise)
- 4 Option exercise President and CEO acquired 193,083 shares (option exercise)
- 4 Option exercise Chief Financial Officer acquired 28,513 shares (option exercise)
- 4 Option exercise Global General Counsel acquired 12,166 shares (option exercise)
Page 4 of 17 · 334 filings